menu search

Biogen's alzheimer's drug to enter new trial stage next year

Biogen's Alzheimer's drug Aduhelm was approved for sale by the FDA in June. But whether or not it actua...

December 16, 2021, 10:00 pm

Endo: fda approves generic form of vasostrict creating headwind into next year

Eagle Pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP's Vasostrict. This approval follows Eagle's co...

December 16, 2021, 1:24 pm

Endo: fda approves generic form of vasostrict creating headwind into next year

Eagle Pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP's Vasostrict. This approval follows Eagle's co...

December 16, 2021, 1:24 pm

Endo: fda approves generic form of vasostrict creating headwind into next year

Eagle Pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP's Vasostrict. This approval follows Eagle's co...

December 16, 2021, 1:24 pm

Cp, kcs await federal approval of now-complete merger

Canadian Pacific has formally completed its acquisition of Kansas City Southern, and both are now waiting for the Surface Transportation Board to...

December 14, 2021, 1:23 pm

Cp, kcs await federal approval of now-complete merger

Canadian Pacific has formally completed its acquisition of Kansas City Southern, and both are now waiting for the Surface Transportation Board to...

December 14, 2021, 1:23 pm

Cp, kcs await federal approval of now-complete merger

Canadian Pacific has formally completed its acquisition of Kansas City Southern, and both are now waiting for the Surface Transportation Board to...

December 14, 2021, 1:23 pm

Daré bioscience's one-time bacterial vaginosis treatment scores fda approval

The FDA has approved Daré Bioscience Inc (NASDAQ: DARE) Xaciato (DARE-BV1) to treat bacterial vagin...

December 7, 2021, 1:07 pm

Daré bioscience's one-time bacterial vaginosis treatment scores fda approval

The FDA has approved Daré Bioscience Inc (NASDAQ: DARE) Xaciato (DARE-BV1) to treat bacterial vagin...

December 7, 2021, 1:07 pm

Daré bioscience's one-time bacterial vaginosis treatment scores fda approval

The FDA has approved Daré Bioscience Inc (NASDAQ: DARE) Xaciato (DARE-BV1) to treat bacterial vagin...

December 7, 2021, 1:07 pm

Aeromexico says bankruptcy court accepts financing commitment letters

Mexican airline Aeromexico said late on Monday a bankruptcy court has approved its commitment letters r...

December 7, 2021, 12:01 am

Aeromexico says bankruptcy court accepts financing commitment letters

Mexican airline Aeromexico said late on Monday a bankruptcy court has approved its commitment letters r...

December 7, 2021, 12:01 am

Aeromexico says bankruptcy court accepts financing commitment letters

Mexican airline Aeromexico said late on Monday a bankruptcy court has approved its commitment letters r...

December 7, 2021, 12:01 am

Tesla's musk says biden's ev bill shouldn't pass

Tesla Inc CEO Elon Musk said on Monday that the U.S. Congress should not approve the Biden administrati...

December 6, 2021, 9:35 pm

Tesla's musk says biden's ev bill shouldn't pass

Tesla Inc CEO Elon Musk said on Monday that the U.S. Congress should not approve the Biden administrati...

December 6, 2021, 9:35 pm

Tesla's musk says biden's ev bill shouldn't pass

Tesla Inc CEO Elon Musk said on Monday that the U.S. Congress should not approve the Biden administrati...

December 6, 2021, 9:35 pm

Pharmaxis stocks rising with new drugs coming online in 2022, says broker

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF), a biotech targeting fibrosis and inflammation, has released two FDA-approved respiratory drugs and a pipeline o...

December 6, 2021, 12:44 am

Pharmaxis stocks rising with new drugs coming online in 2022, says broker

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF), a biotech targeting fibrosis and inflammation, has released two FDA-approved respiratory drugs and a pipeline o...

December 6, 2021, 12:44 am

Pharmaxis stocks rising with new drugs coming online in 2022, says broker

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF), a biotech targeting fibrosis and inflammation, has released two FDA-approved respiratory drugs and a pipeline o...

December 6, 2021, 12:44 am

Blueprint medicines' (bpmc) ayvakit aids growth amid rivalry

Blueprint Medicines' (BPMC) Ayvakit, which has been approved to treat PDGFRA Exon 18 mutant gastrointes...

December 3, 2021, 1:45 pm


Search within

Pages Search Results: